Ngenla

Active Ingredient(s): Somatrogon-ghla
FDA Approved: * June 27, 2023
Pharm Company: * PFIZER IRELAND PHARMACEUTICALS
Category: Growth Hormone Treatment
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ngenla 24 mg/1.2ml Subcutaneous Injection, Solution
NDC: 0069-0505
Labeler:
Pfizer Laboratories Div Pfizer Inc
Ngenla 60 mg/1.2ml Subcutaneous Injection, Solution
NDC: 0069-0520
Labeler:
Pfizer Laboratories Div Pfizer Inc